Home of the GBM AGILE trial,
our mission is to speed the
discovery and development of
cures for patients with rare
and deadly diseases.
The Global Coalition for Adaptive Research (GCAR) is an international partnership comprised of some of the world’s foremost clinical, translational, and basic science investigators. Through this collaboration and open exchange of ideas, the ultimate beneficiary—the patient—is supported in the fight against rare and deadly diseases.
READ MORE